METHODS: A retrospective review was performed of patients treated with Woven Endobridge from March 2013 to March 2018. Primary efficacy outcomes were defined as per Raymond-Roy Occlusion Criteria (RROC) resulting in long-term complete occlusion (RROC1) and adequate occlusion (RROC1 and RROC2). Primary Safety outcomes were defined as procedure-related morbidity, rate of re-bleeding and rate of re-treatment.
RESULTS: Seventy-nine aneurysms were treated during the five-year period. Adequate aneurysm occlusion (RROC1 and RROC2) achieved was 81%. Retreatment was required in 18% of patients (14/79). Greater retreatment rate was demonstrated in partially thrombosed aneurysms, aneurysms with larger neck and dome diameter and dome heights.
CONCLUSIONS: Woven Endobridge treatment of wide-neck intracranial aneurysms offers a safe and efficacious outcome. This large UK single-centre experience demonstrates congruity with recent five-year outcomes of WEBCAST and WEBCAST2 trials.
方法:对2013年3月至2018年3月期间接受WovenEndobridge治疗的患者进行回顾性分析。根据Raymond-Roy闭塞标准(RROC)定义主要疗效结果,导致长期完全闭塞(RROC1)和充分闭塞(RROC1和RROC2)。主要安全性结果定义为与手术相关的发病率,再出血率和再治疗率。
结果:在五年期间治疗了79个动脉瘤。达到的足够动脉瘤闭塞(RROC1和RROC2)为81%。18%的患者需要重新治疗(14/79)。在部分血栓形成的动脉瘤中显示出更高的再治疗率,具有较大颈部和圆顶直径和圆顶高度的动脉瘤。
结论:WovenEndobridge治疗颅内宽颈动脉瘤可提供安全有效的结果。这个大型英国单中心的经验证明了与WEBCAST和WEBCAST2试验最近五年的结果一致。